Small Cell Lung Cancer: A New Era Is Beginning?
Small-cell lung cancer (SCLC) is the most aggressive form of lung cancer: No significant progress has been made in finding new treatments for decades and platinum-based chemotherapy has for a long time represented the standard of care. This therapeutic scenario has recently changed, thanks to positi...
محفوظ في:
| التنسيق: | Online |
|---|---|
| اللغة: | الإنجليزية |
| منشور في: |
MDPI - Multidisciplinary Digital Publishing Institute
2022
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | ONIX_20220111_9783036523019_772 |
| الوسوم: |
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة: Small Cell Lung Cancer: A New Era Is Beginning?
- Non-small Cell Lung Cancer: Current Therapies and New Targeted Treatments
- Second Line Treatment of Non-Small Cell Lung Cancer: Clinical; Pathological and Molecular Aspects of Novel Promising Drugs
- Prevention, Diagnosis and Treatments of Early-Stage NSCLC
- Immunotherapy, Tumor Microenvironment and Survival Signaling
- Therapeutic Monoclonal Antibodies and Antibody Products, Their Optimization and Drug Design in Cancers
- Personalized Medicine in Oncology